maritide weight loss - Search News

News

weight loss, Mounjaro and Ozempic

New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss’

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials. Drugs like Wegovy and Mounjaro – or diabetes jab

NBC News on MSN · 3d

Monthly weight loss drug helps people lose 20% of body weight, trial finds

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase 2 clinical trial.

LADbible · 3d

Ozempic and Mounjaro have new competitor as trial sees people lose 20% of body weight in one year

The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly basis rather than weekly.

This Once-a-Month Ozempic Rival Just Delivered Big Results

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Medical Dialogues12h

Once-Monthly MariTide Shows Promising Weight Loss in Obesity and Type 2 Diabetes: Phase 2 Trial

MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...

Zacks.com on MSN4h

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.

TCTMD1d

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

The once-monthly drug is still under study but could provide added convenience and another option for patients.

New Atlas1d

A once-monthly jab cuts body weight by 16% in groundbreaking obesity trial

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

3don MSN

Amgen Shares Fall on Weight-Loss Drug Tummy Troubles

Amgen shares fell sharply on Monday afternoon after the company released results from a weight-loss trial that showed that ...

Amgen Expands MariTide Development Plans After Successful Weight-Loss Trial

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

BioPharma Dive3d

New Amgen obesity drug data disappoint Wall Street

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results